Chapter 28 The Burden

Cancer in Northern Africa, Central and West Asia

In 2023, Egypt became the first country to achieve WHO validation on the path to elimination of hepatitis C with the country’s epidemic expected to end before 2030.

Northern Africa, Central and West Asia is a diverse region characterized by relatively low but increasing cancer incidence rates. Breast cancer is the most common cancer in both sexes combined in all countries but Egypt (liver cancer), Kyrgyzstan and Tajikistan (stomach cancer), and Azerbaijan, Armenia, Tunisia, Türkiye (lung cancer) (Map 28.1).

This diverse region is undergoing major epidemiologic transition, with changes in population demographics and an increasing prevalence of risk factors contributing to a possible doubling of the cancer burden by 2050.

The three subregions have quite distinct cancer profiles (Figure 28.1). In Northern Africa, liver cancer is the second most common cancer among both sexes after breast cancer, with incidence and mortality rates in Egypt estimated to be the second highest worldwide in both men and women, largely due to the high prevalence of hepatitis C virus infection in the country.

In Central Asia, the observed cancer profiles are consistent with low to medium human development index (HDI) countries, with a high incidence of infection-related cancers, in particular, stomach cancer (10% of all cancer cases), as well as cervical cancer (see Human Development Index). Lung cancer mortality rates are second to breast cancer in the region (Figure 28.2).

Figure 28.1

Estimated number of new cancer cases by type (excluding non-melanoma skin cancer) in Northern Africa, Central and West Asia, 2022

Breast
Liver
Lung
Colorectum
Bladder
Prostate
Stomach
Cervix uteri
Thyroid
Other specified cancers

Northern Africa

Central Asia

West Asia

West Asia is a large and diverse region, with specific cancer profiles corresponding to their high national levels of HDI, while also reflecting high levels of smoking in some countries, low alcohol consumption, as well as high prevalence of excess body fatness. Breast cancer is the most common cancer in both sexes combined, followed by lung cancer (Figure 28.1), the latter of which is also the most common cause of death from cancer in the region (Figure 28.2).

 

Figure 28.2

Incidence and mortality, age-standardized rates (world) per 100,000, for the most common cancer types in Northern Africa, Central and West Asia, 2022

Incidence
Mortality

NORTHERN AFRICA

CENTRAL ASIA

WEST ASIA

Footnote

CNS: Central nervous system, NHL: Non-Hodgkin lymphoma

The overall number of cancer cases in Northern Africa, Central and West Asia, estimated at close to 900,000 in 2022, is predicted to more than double to 1.9 million cases by 2050. While population growth and population aging are the critical drivers of this increase, incidence rates of common cancers are expected to rise in many of the constituent countries due to changes in lifestyle and the built environment, including tobacco use, unhealthy diet, rising excess body fatness, and insufficient physical activity, making a compelling case for effective implementation of cancer prevention policies.

Sources

Regional definitions

  • North Africa (Algeria, Egypt, Libya, Morocco, Sudan, Tunisia); Central Asia (Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan); West Asia (Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, State of Palestine, Syrian Arab Republic, Türkiye, United Arab Emirates, Yemen)

Text

  • Znaor A, Fouad H, Zahwe M, Eser S, Fadhil I, Soerjomataram I, Hammerich A, Bray F. Cancer surveillance in the Eastern Mediterranean Region: a 10-year IARC-WHO EMRO collaboration. Lancet Oncol, in press.
  • Lyons G, Sankaranarayanan R, Millar AB, Slama S. Scaling up cancer care in the WHO Eastern Mediterranean Region. East Mediterr Health J. Apr 5 2018;24(1):104-110.

Maps

  • Map 28.1: Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today (version 1.1). Lyon, France: International Agency for Research on Cancer. https://gco.iarc.who.int/today.

Figures

  • Figures 28.1-28.4: Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today (version 1.1). Lyon, France: International Agency for Research on Cancer. https://gco.iarc.who.int/today.